Supplement: A Very Expensive Disease

A Very Expensive DiseaseBy Anne HardingFlaws in the system add to the tens of billions spent on schizophrenia every year, but advocates say there's little will to invest in fixing it. ARTICLE EXTRASThe DiseaseLiving with SchizophreniaRobin CunninghamMarianne EmanuelSchizophrenia in ChildhoodWhen Janet Edelman's brother became ill with schizophrenia, she and her parents went through a period of mourning for what they - and the rest of the world - had lost. "My brother should have been a profess

Written byAnne Harding
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

The Disease

Living with Schizophrenia

Robin Cunningham

Marianne Emanuel

Schizophrenia in Childhood

When Janet Edelman's brother became ill with schizophrenia, she and her parents went through a period of mourning for what they - and the rest of the world - had lost. "My brother should have been a professional of some sort. He was bright, he was a good student, he was a very lovely person," says Edelman. "At 16, when the illness struck, he became derailed; all that promise was not fulfilled."

Now, at 54, her brother is receiving excellent care, thanks largely to his family's efforts. He lived with them up until five years ago, and is now in a residential program. "My parents are very good advocates and have been able to get him the services he needs, but not everyone is so lucky," Edelman says. "He's still a very kind and gentle person," she adds. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies